Ginkgo Bioworks Holdings, Inc. (DNA) Stock
Key stats
- Market cap
- $664.46M
- Price / Earnings ratio
- -3.1x
- EPS (TTM)
- -$4.20
- Volume
- Loading
- 52-week high
- $18.22
- 52-week low
- $5.37
Source: third-party data provider, as of November 13, 2026
Compare with DNA
Recent news
Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
DNA
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
DNA
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market
DNA
This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled
This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled
DNANews tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 47.22
- MACD 12/26/9
- 0.21
- EMA 9 of MACD
- 0.27
- MACD histogram
- -0.06
- SMA 50
- $10.17
- Price above SMA 50
- EMA 50
- $10.38
- Price below EMA 50
- SMA 200
- $8.63
- Price above SMA 200
- EMA 200
- $9.12
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Sell
Based on 2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of -$1.13 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news
Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
DNAGinkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
DNAHere's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market
DNAThis Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled
This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled
DNA
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
DNA
Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
DNA
Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains?
Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains?
DNA
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts
DNA
Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data
Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data
DNA
Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines
Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines
DNANews tone: automated (AI) classification of the article's content, not a price prediction.
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Jason Kelly Ph.D. | Co-Founder, Co-COO, CEO & Director | 1981 |
| Mr. Steven P. Coen CPA | Chief Financial Officer | 1966 |
| Ms. Jennifer Wipf | Co-Chief Operating Officer | — |
| Dr. Reshma P. Shetty | Co-Founder, President & Director | 1981 |
| Mr. Thomas Knight Jr. | Founder | — |
| Mr. Austin Che Ph.D. | Co-Founder & Head of Strategy | — |
| Mr. Bartholomew Canton Ph.D. | Co-Founder & CTO | — |
| Ms. Karen Tepichin | General Counsel & Secretary | — |
| Mr. Daniel Marshall | Senior Manager of Communications & Ownership | — |
| Mr. Brian O'sullivan | Head of Commercial | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 47.22
- MACD 12/26/9
- 0.21
- EMA 9 of MACD
- 0.27
- MACD histogram
- -0.06
- SMA 50
- $10.17
- Price above SMA 50
- EMA 50
- $10.38
- Price below EMA 50
- SMA 200
- $8.63
- Price above SMA 200
- EMA 200
- $9.12
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $5.00
- Average
- $8.00
- High
- $11.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -8.5 | -27.0 | ||||||||||
| 2022 | -31.2 | -27.7 | -6.1 | -31.0 | -1.6 | -20.1 | +20.2 | -6.3 | +13.9 | -13.1 | -27.4 | -14.6 |
| 2023 | +23.4 | -26.5 | -5.0 | -3.9 | +33.9 | +10.7 | +41.0 | +0.0 | -19.6 | -19.9 | -5.1 | +18.2 |
| 2024 | -27.5 | +19.7 | -10.1 | -20.4 | -37.2 | -38.3 | +17.6 | -54.8 | +33.6 | +0.3 | +12.3 | +2.2 |
| 2025 | +30.7 | -35.9 | -28.8 | +30.2 | -0.1 | +57.8 | +15.7 | +3.9 | +32.3 | -11.5 | -27.4 | -3.9 |
| 2026 | +3.1 | -26.3 | -13.0 | +24.6 | -3.4 | +8.4 | -21.3 | -23.8 | +85.1 | -10.3 | +4.1 |
